Αποτελέσματα Αναζήτησης
9 Σεπ 2024 · We conducted a systematic review of evidence on the efficacy and safety of a two-dose regimen (10 µg per dose) of Pfizer-BioNTech COVID-19 vaccine in children aged 5─11 years. We assessed outcomes and evaluated the quality of evidence using a modified GRADE approach.
FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age. The FDA amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and...
EUA amendment request for Pfizer-BioNTech COVID-19 Vaccine for use in children 5 through 11 years of age
19 Οκτ 2022 · Covid-19 messenger RNA vaccines, including mRNA-1273 (Moderna), are safe and efficacious in preventing illness from SARS-CoV-2 infection in adults, 11,12 adolescents, and older children (6 to...
30 Δεκ 2021 · On October 29, 2021, the Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for Pfizer-BioNTech COVID-19 (BNT162b2) mRNA vaccine to expand its use to children aged 5–11 years, administered as 2 doses (10 μg, 0.2mL each) 3 weeks apart (1).
9 Νοε 2021 · A Covid-19 vaccination regimen consisting of two 10-μg doses of BNT162b2 administered 21 days apart was found to be safe, immunogenic, and efficacious in children 5 to 11 years of age....
29 Οκτ 2021 · Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age.
